Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Predict S.P.A. Class B ( (IT:PRE) ) has issued an announcement.
Predict S.p.A. has signed a new distribution agreement with Airs Medical Europe for SwiftMR®, an AI-enhanced software that reduces MRI scan times by up to 50% while maintaining image quality. This agreement, covering the Puglia region, strengthens Predict’s portfolio in diagnostic imaging and aligns with its strategic goals of enhancing healthcare efficiency and accessibility. The integration of SwiftMR® into existing workflows without additional equipment requirements promises increased productivity and operational continuity for healthcare facilities.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A., founded in 2008 in Bari, is an innovative SME in the healthcare sector, specializing in in vivo diagnostics, breath analysis, and digital healthcare technologies. The company operates through four Strategic Business Units, focusing on diagnostic imaging, breath analysis, and augmented reality and robotics solutions for healthcare professionals. Predict has developed several in-house technologies and maintains partnerships with leading Italian universities and research institutes.
Average Trading Volume: 27,807
Technical Sentiment Signal: Strong Buy
See more data about PRE stock on TipRanks’ Stock Analysis page.